Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

10/24/24 503(b)2 Ghost generics

October 24, 2024

The attached slides are from a presentation given at HCP outlining the traps and pitfalls of the new 503(b)2 approval pathway.  They are a bit on the small side.

HCP Ghost Generics 503(b)2

 

Michael R McDaniel, R.Ph., MBA, FASHP
Executive Director, System Pharmacy Services
Huntsville Hospital/HH Health System
256-265-8419






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved